Šeštadienis, gruodžio 14 d.

Norvegija-Oslas: Gripo vakcinos

Norvegija-Oslas: Gripo vakcinos


I dalis: Perkančioji organizacija

    I.1) Pavadinimas ir adresai:

      Oficialus pavadinimas: Folkehelseinstituttet
      Adresas: Lovisenberggata 8
      Miestas: OSLO
      Pašto kodas: 0456
      Šalis: Norvegija
      Asmuo ryšiams: Ole Andreas Fuglesang
      El-paštas: ole.andreas.fuglesang@fhi.no
      Interneto adresas (-ai):
      Pagrindinis adresas: http://www.fhi.no

II dalis: Objektas

    II.1.1) Pavadinimas:

      Enhanced quadrivalent influenza vaccine against seasonal influenza for the 2023/2024 influenza season
      Nuorodos numeris: 22/03656

    II.1.2) Pagrindinis BVPŽ kodas:

      33651660 Gripo vakcinos ;

    II.1.3) Sutarties tipas:

      Prekės
;

    II.1.4) Trumpas aprašymas:

      The Norwegian Institute of Public Health (FHI) has carried out an open tender for an Enhanced quadrivalent influenza vaccine against seasonal influenza for vaccination of particularly vulnerable persons from 65 years and older (nursing home residents, users of home nursing care, etc.) An enhanced quadrivalent influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups in the national vaccination programme.
      The aim was to enter into a contract for the delivery of 80,000 doses of enhanced quadrivalent influenza vaccine. It is important that the enhanced quadrivalent influenza vaccine can be delivered in time for FHI to distribute vaccine doses to end users in all of Norway's municipalities, before the flu season starts.

    II.2) Aprašymas:

    II.2.1) Kitas (-i) šio pirkimo BVPŽ kodas (-ai):

      33651600 Vakcinos
      33651660 Gripo vakcinos
Svetainė yra atnaujinama. Galimi smulkūs nesklandumai.